Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAB01 in Healthy Participants
NCT07815561Phase 1Recruiting
- Sponsor
- Santa Ana Bio
- Start
- Aug 2026
- Primary completion
- Apr 2027
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of SAB01 (13 arms), sponsored by Santa Ana Bio. Primary endpoint: Safety and tolerability of single ascending doses of SAB01. Started Aug 2026; status: recruiting.
02
Drugs
SAB01
Beyond the preview
Go deeper on NCT07815561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07815561.